Nov 11, 2020
By Gavin Day
On the same day drug maker Pfizer announced positive news for its coronavirus vaccine, its CEO cashed in millions of dollars in stock.
Albert Bourla sold 5.6-million dollars in stock on Monday.
The sale was done through a predetermined plan created in August.
Pfizer’s vaccine, in partnership with a company called BioNTech, showed a 90% percent effectiveness rate in preliminary results.
The company’s stock jumped 8% on the news.